After years of caring for others, Auckland nurse Zazi Gohar faced her own health crisis when she was diagnosed with multiple ...

Patients receiving chemotherapy in Lincolnshire can now have additional treatment to help reduce their hair loss. Many cancer ...

Women had a lower probability of receiving any disease-modifying treatment (DMT) and were even less likely to get ...

Among 282 patients with pediatric-onset MS, 39% started high-efficacy therapy early (at ages 12-17), and 61% started late ...

The Bruton's tyrosine kinase inhibitor tolebrutinib is reportedly the first agent to show benefit in patients with nonrelapsing secondary progressive MS.

Sangeetha Venugopal, MD, MS, discussed the evolving landscape of acute myeloid leukemia treatment as well as unmet needs ...

Vitamin D is linked to a 34% reduction in the relative risk for disease activity in patients with clinically isolated ...

Researchers have identified biomarkers that can predict disease progression in multiple sclerosis, which could lead to the ...

Her local Member of the Senedd (MS), and Plaid Cymru's health spokesperson Mabon ap Gwynfor, said long waiting lists for NHS ...

Available disease-modifying therapies can prevent relapses and relapse-associated worsening in people with multiple sclerosis by targeting autoimmunity through various mechanisms. However, these ...

A pioneering study presented today at ECTRIMS 2024 has identified critical biomarkers that can predict disability worsening in multiple sclerosis (MS).

A study presented at ECTRIMS 2024 has identified critical biomarkers that can predict disability worsening in multiple ...